Article Text

Download PDFPDF
EBM distance learning course to support judicial decisions on healthcare: a case study
  1. Carisi Anne Polanczyk1,2,
  2. Amanda Maciel de Quadros1,
  3. Andreia Turmina Fontanella1,
  4. Angélica Dutra Zanotto1,
  5. Fernanda d Athayde Rodrigues1,3,
  6. Denizar Araujo Vianna1,4,
  7. Cristiana Maria Toscano1,5,
  8. Rachel Riera6,7,
  9. Luiz Fernando Lima Reis8
  1. 1 Instituto de Avaliação de Tecnologia em Saúde, Porto Alegre, Brazil
  2. 2 Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
  3. 3 Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
  4. 4 Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil
  5. 5 Universidade Federal de Goias, Goiania, Brazil
  6. 6 Discipline of Evidence-based Medicine, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil
  7. 7 Center of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, São Paulo, Brazil
  8. 8 Hospital Sirio-Libanes, Sao Paulo, Brazil
  1. Correspondence to Dr Fernanda d Athayde Rodrigues, Instituto de Avaliação de Tecnologia em Saúde, Porto Alegre 97017660, Brazil; fe.athayde{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Between 2008 and 2017, health-related legal demands have increased 130% in Brazil.1 In 2016, the 10 most expensive drugs that were legally required comprised 91% of the resources guaranteed for the acquisition of technologies by the Brazilian government.1 These drugs were intended for 1213 users of Brazilian Public Health System (SUS), which covers 140 million Brazilians. In this scenario, it has been necessary to adopt strategies to enhance the judicial process, ensuring evidence-informed judicial decisions.

Through a broad project of the Brazilian Ministry of Health, formally named PROADI-SUS, a collaborative agreement has been established between Hospital Sírio-Libanês and the National Council of …

View Full Text

Footnotes

  • CAP, DAV, RR and LFLR are joint senior authors.

  • Twitter @RieraRachel

  • Contributors Conception and design: CAP, CMT, DAV, LFLR. Data collection: AMdQ, ATF, ADZ, FdAR. Manuscript draft: CAP, FdAR, AMdQ, ADZ. Content revisor: CAP, DAV, CMT, RR, LFLR. Final approval: all authors.

  • Funding This study was supported by the Brazilian Ministry of Health through the Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde (PROADI-SUS Program), led by Hospital Sírio- Libanês, São Paulo, Brazil.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.